BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25922903)

  • 1. Evaluation of the Efficacy, Safety, and Tolerability of 3 Dose Regimens of Topical Sodium Nitrite With Citric Acid in Patients With Anogenital Warts: A Randomized Clinical Trial.
    Ormerod AD; van Voorst Vader PC; Majewski S; Vanscheidt W; Benjamin N; van der Meijden W
    JAMA Dermatol; 2015 Aug; 151(8):854-61. PubMed ID: 25922903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts.
    Gilson RJ; Ross J; Maw R; Rowen D; Sonnex C; Lacey CJ
    Sex Transm Infect; 2009 Dec; 85(7):514-9. PubMed ID: 19700413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial.
    Tatti S; Swinehart JM; Thielert C; Tawfik H; Mescheder A; Beutner KR
    Obstet Gynecol; 2008 Jun; 111(6):1371-9. PubMed ID: 18515521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts.
    Bonnez W; Elswick RK; Bailey-Farchione A; Hallahan D; Bell R; Isenberg R; Stoler MH; Reichman RC
    Am J Med; 1994 May; 96(5):420-5. PubMed ID: 8192173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men.
    Rosen T; Nelson A; Ault K
    Cutis; 2015 Oct; 96(4):277-82. PubMed ID: 26682290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
    Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
    AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
    Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
    Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts.
    Gross G; Meyer KG; Pres H; Thielert C; Tawfik H; Mescheder A
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1404-12. PubMed ID: 17958849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
    Senatori R; Dionisi B; Lippa P; Inghirami P
    Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
    Matteelli A; Beltrame A; Graifemberghi S; Forleo MA; Gulletta M; Ciravolo G; Tedoldi S; Casalini C; Carosi G
    Sex Transm Dis; 2001 Jun; 28(6):343-6. PubMed ID: 11403192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
    Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
    J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
    Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
    JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
    Syed TA; Lundin S; Ahmad SA
    Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.
    Tyring S; Edwards L; Cherry LK; Ramsdell WM; Kotner S; Greenberg MD; Vance JC; Barnum G; Dromgoole SH; Killey FP; Toter T
    Arch Dermatol; 1998 Jan; 134(1):33-8. PubMed ID: 9449907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.